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The neonatal Fc receptor (FcRn) extends the systemic half-life of IgG antibodies by chaperoning bound Fc away from lysosomal
degradation inside stromal and hematopoietic cells. FcRn also transports IgG across mucosal barriers into the lumen, and yet
little is known about how FcRnmodulates immunity in the lung during homeostasis or infection. We infected wild-type (WT)
and FcRn-deficient (fcgrt/) mice with Pseudomonas aeruginosa or Mycobacterium tuberculosis to investigate whether recy-
cling and transport of IgG via FcRn influences innate and adaptive immunity in the lung in response to bacterial infection. We
found that FcRn expressionmaintains homeostatic IgG levels in lung and leads to preferential secretion of low-affinity IgG li-
gands into the lumen. Fcgrt/ animals exhibited no evidence of developmental impairment of innate immunity in the lung and
were able to efficiently recruit neutrophils in a model of acute bacterial pneumonia. Although local humoral immunity in lung
increased independently of the presence of FcRn during tuberculosis, there was nonetheless a strong impact of FcRn deficiency
on local adaptive immunity. We show that the quantity and quality of IgG in airways, as well as the abundance of dendritic cells
in the lung, are maintained by FcRn. FcRn ablation transiently enhanced local T cell immunity and neutrophil recruitment dur-
ing tuberculosis, leading to a lower bacterial burden in lung. This novel understanding of tissue-specific modulation of mucosal
IgG isotypes in the lung by FcRn sheds light on the role of mucosal IgG in immune responses in the lung during homeostasis and
bacterial disease.
Secretory immunoglobulin A (IgA) and IgM are exported by adedicated receptor to the mucosa, where they coat pathogens
and nurture beneficial microbiota (1). Yet the idea of the immune
predominance of IgA in mucosal secretions has been challenged
by the identification of the neonatal Fc receptor (FcRn) atmucosal
sites in adult mammals (2). FcRn binds to conserved elements of
the Fc portion of IgG at low pH, transports IgG across polarized
epithelial barriers, and chaperones IgG between endocytic and
degradative compartments (3). Selective expression of FcRn in
epithelium was also found to enable antigens bound to IgG to be
retrieved from the lumen to initiate systemic immunity to Citro-
bacter rodentium (4). FcRn guides monomeric IgG to the endo-
cytic excretion pathway, extending its serum half-life by prevent-
ing lysosomal degradation (5). Finally, intracellular trafficking of
antibody complexes within antigen-presenting cells via FcRn can
influence lymphocyte activation with respect to opsonized parti-
cles (6, 7). Despite FcRn being the primary means by which IgG is
transported across epithelial barriers, conflicting reports in a va-
riety of infection models have questioned whether FcRn is re-
quired for the protective action ofmucosal IgG, implying immune
roles at themucosal interface beyond neutralization of pathogenic
determinants (8–10).
Inhaled air passes constantly through the lungs, continually
introducing particulate and microbial matter into the lower air-
ways, where it interacts with secreted antibodies. Many of the
studies cited above have shed light on the role of FcRn-mediated
IgG regulation and transport specifically in the gastrointestinal
tract. Knowledge of the role of FcRn in the lung remains limited,
although expression has been identified in parenchyma and re-
cruited immune cells (11, 12). Indeed, FcRn has been harnessed to
provide inhaled Fc-fusion vaccines access to systemic immunity
(13, 14).We are interested in how IgG interactions with FcRnmay
be involved in homeostatic immune development in the lung and
also in defense against respiratory infections by two bacterial spe-
cies that require orchestrated multicomponent immune re-
sponses. The first, Pseudomonas aeruginosa, is an opportunistic
pathogen that rapidly recruits innate immune cells to the lung
parenchyma and is sensitive to complement deposition (15). The
second,Mycobacterium tuberculosis, is a slow-growing pulmonary
pathogen that disseminates to peripheral organs. Exponential
growth in the lung is arrested by the arrival of specific Th1 T cells
in the lung approximately 2 to 3 weeks after infection which pro-
mote formation of granulomas composed of diverse myeloid and
lymphoid cells (16). Antibodies are thought to play a limited pro-
tective role in naturalM. tuberculosis infection despite strong local
recruitment of B cells to granulomas (17, 18). By studying fcgrt/
mice during homeostasis and bacterial infection, we aimed to
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characterize specific immune roles for IgG at the lung interface
with the external environment.
MATERIALS AND METHODS
Bacteria. Mycobacterium bovis BCG SSI 1331 (American Type Culture
Collection [ATCC]; no. 35733), VPM1002 (recombinant BCG [rBCG]),
and M. tuberculosis H37Rv (ATCC; no. 27294) stock was prepared as
described previously (19). To generate green fluorescent protein (GFP)-
expressingM. tuberculosis, competent H37Rv was transformed with plas-
mid pGFM-11 by electroporation and selected with kanamycin (20). P.
aeruginosa strain PAO1 (PAO1-DSM; German Collection for Microor-
ganisms and Cell Cultures) was grown in Luria broth (LB) at 37°C to the
late exponential/early stationary phase and then subcultured for 2 h at
37°C to the mid-exponential phase before use. For CFU enumeration of
the two pathogens, serial dilutionswere performed in phosphate-buffered
saline–0.05% Tween 80 (PBST) and plated onto Middlebrook 7H11 agar
or LB agar and incubated at 37°C for 3 to 4 weeks or 16 h, respectively.
Experimental animals and manipulations. Fcgrt/ and P25 trans-
genic mice were purchased from Jackson Laboratories (USA) and bred
in-house alongside C57BL/6 controls. Female mice were 8 to 16 weeks of
age at the beginning of the experiments and were matched for age and sex
and distributed randomly between treatment groups. Mice were kept un-
der specific-pathogen-free (SPF) conditions at the Max Planck Institute
for Infection Biology in Berlin, Germany, and experiments were carried
out according to institutional guidelines approved by the local ethics com-
mittee of the German authorities (Landesamtes für Gesundheit und So-
ziale). For vaccination studies, P. aeruginosa strain PAO1 was killed by
incubation for 2 h in 1% paraformaldehyde at 37°C and then washed 3
times in phosphate-buffered saline (PBS). Killing was confirmed by plat-
ing this preparation, and then the solution was adjusted to deliver 1 107
bacteria per 6 l dose into both nostrils at days 0, 8, and 14. Mice were
infected intratracheally (i.t.) 40 days after vaccination or sham PBS treat-
ment with 4 106 P. aeruginosa strain PAO1 cells under mild anesthesia.
A Glas-Col inhalation exposure system was used for aerosol infection of
mice with low-dose (100 CFU)M. tuberculosis, confirmed by plating lung
homogenates 1 day after infection. For generation of bone marrow chi-
meras,micewere irradiatedwith 9Gy and immune reconstitutedwith 1
106 bone marrow cells the following day. Chimeric mice were offered
drinking water containing 125 mg/liter enrofloxacin (Bayer) for 4 weeks
and allowed to recover for 12 weeks.
Sample preparation. Bronchoalveolar lavage was performed with 500
l PBS supplemented with protein inhibitors (Roche) for antibody anal-
ysis. For antibody and CFU analysis, lungs were homogenized in PBST
and protein inhibitors using GentleMACS dissociator M tubes (Milte-
nyi Biotec). For flow cytometry, lungs were harvested from perfused
animals and digested with collagenase (0.7 mg/ml collagenase IV [Sig-
ma-Aldrich]–0.3 mg/ml collagenase D [Roche])–RPMI 1640 medium at
37°C in 5% CO2 for 30 min. Single-cell suspensions were prepared by
mechanical dissociation through a 70-m-pore-size nylon mesh using
RPMI 1640 medium with 10% fetal calf serum (Gibco).
Flow cytometry. Single-cell suspensions were stained on ice with
the following eBioscience antibodies: B220 (RA3-6B2), Siglec-F
(1RNM44N), CD103 (2E7), CD11b (MI-70), CD11c (N418), CD8 (53-
6.7), CD69 (H1-2F3), CD4 (RM4-5), CD3ε (145-2C11),  T cell recep-
tor (TCR) (GL3), NK1.1 (PK136), CD44 (IM7), Ly6G (1A8), Ly6C
(HK1.4), MHCII (M5), and XCR1 (ZET; BioLegend). Intracellular IgG2c
was detected with polyclonal goat antiserum (Southern Biotech) using
Cytofix/Cytoperm (BectonDickinson). Analysis was performed on LSR II
or FACSCanto II (Becton Dickinson) flow cytometers. Data were ana-
lyzed with FlowJo (TreeStar).
Antibody and isotype measurements. For quantification of total or
M. tuberculosis-specific antibodies, Multisorb enzyme-linked immu-
nosorbent assay (ELISA) plates (Nunc) were coated overnight with goat
anti-mouse antibody (Chemicon) (2 g/ml of anti-Ig heavy and light
chain) or protein lysate prepared by sonicating log-phase H37Rv M. tu-
berculosis. Nonspecific binding was blocked with 3% bovine serum albu-
min (Gibco). Serial dilutions were detected at an optical density (OD) of
405 using alkaline phosphatase-conjugated isotype-specific secondary an-
tibodies (Southern Biotech). The abundance of various isotypes wasmea-
sured using Procarta Isotyping Panel 2Multiplex (eBioscience), acquired,
and analyzed by Bioplex (Bio-Rad).
Immunohistochemistry. Sections (3 m thick) of formalin-fixed
lung were deparaffinized, and antigen retrieval was performed in citrate
buffer. Cell membranes were permeabilized with 1% saponin and then
blocked with 10% goat serum (Gibco) and a biotin/avidin blocking prep-
aration (Dako). Endogenous IgG2b was detected with biotinylated poly-
clonal goat anti-mouse antibody (Southern Biotech) followed by strepta-
vidin-Cy2 (Dako), while treatment with polyclonal rabbit anti-human
myeloperoxidase (Dako) was followed by goat anti-rabbit serum con-
jugated to Cy3 (Dako). DAPI (4=,6-diamidino-2-phenylindol) (Sigma)
was used to identify cell nuclei.
Statistical analysis. PRISM (Graphpad) was used for statistical anal-
ysis. Data that did not pass the Shapiro-Wilk normality test were analyzed
using the nonparametric Mann-Whitney test. Normally distributed data
were compared using the two-way Student’s t test or one-way analysis of
variance (ANOVA) followed byDunnett’s posttest depending onwhether
data fromone group or from two ormore groups, respectively, were being
compared.
RESULTS
FcRn regulates the quantity and quality of IgG in lung secre-
tions. IgG from local and systemic immune responses is main-
tained in tissues and transported through the mucosa by binding
to FcRn. We measured the relative abundances of antibody iso-
types in serum, homogenized lung tissue, and bronchoalveolar
lavage fluid (BALF) of wild-type (WT) and fcgrt/mice to deter-
mine how ablation of IgG recycling or transport across lung epi-
thelia influences homeostatic immunity in the lung. As previously
described (3), fcgrt/ animals displayed reduced serum IgG lev-
els, reflecting the well-described role of the FcRn extending the
half-life of systemic IgG. This reduction in IgG isotypes was like-
wise observed in fcgrt/ lung parenchyma, implying that sys-
temic IgG supplies tissues via diffusion from the circulation. Our
analysis of antibody in BALF of WT and fcrgt/ mice revealed
that, unlike IgM and IgA, luminal IgG strongly depended on FcRn
expression, as fcgrt/mice had 10- to 100-fold lower concentra-
tions of locally dominant IgG isotypes. Intriguingly, the ratio of
isotypes found in the airways of WT mice diverged from that
observed in serum, such that IgG2b and IgG3 were the dominant
antibody isotypes secreted into the mucosa. This discordant Ig
isotype ratio depended on FcRn expression, as the levels of IgG
isotypes in fcgrt/ lung more closely mirrored serum and tissue
levels (Fig. 1A). Thus, FcRn in the lung qualitatively and quanti-
tatively influences IgG in mucosal secretions.
FcRn modifies homeostatic myeloid immune subsets in
lung. We performed immune phenotyping of lung-resident im-
mune cells in WT and fcgrt/ animals to determine whether this
receptor influences local leukocyte homeostasis. While most im-
mune cell populations were comparable between strains, in the
absence of FcRn we observed increased numbers of lung-resident
XC chemokine receptor 1-positive (XCR1) CD103 dendritic
cells (DC) compared to the results seen withWT animals (Fig. 1B
and C). This correlated with increased homeostatic mRNA tran-
scription of itgae (CD103) in lung, the DC growth factor flt3, and
CD103 DC-specific transcription factors batf3 and irf8 (see Fig.
S1 in the supplemental material). However, expression of
CD11b DC-associated transcription factor irf4 was not influ-
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enced by FcRn expression (see Fig. S1). These data suggest that
pulmonary IgG dampens local DC recruitment or differentiation
during neonatal development or homeostasis. There was no evi-
dence of ongoing inflammation in resting animals, as the two
strains had similar numbers of local lymphocytes, and no differ-
ences were seen in the number or ratio of effectormemory CD44hi
CD62lo T cells in lung (see Fig. S2).
FcRn is redundant for lung immunity toP. aeruginosa. FcRn
is expressed by myeloid cells and modulates lung DC populations
and thus may influence local immunity to infection. In order to
assess the role of luminal and intracellular IgG transport during
acute bacterial infection requiring efficient recruitment of innate
leukocytes, we first vaccinated WT and FcRn-deficient (fcgrt/)
mice intranasally with formalin-killed P. aeruginosa to generate a
pool of specific IgG in the lung as previously described (21). Vac-
cinated and sham-treated animals were challenged via intratra-
cheal administration with virulent P. aeruginosa to determine
whether local immunity was compromised in the absence of mu-
cosal IgG and in the presence of lower levels of homeostatic IgG
circulation in fcgrt/ animals. WT and fcgrt/ mutants were
equally susceptible to acute bacterial pneumonia, suggesting that
local IgG binding to FcRn is dispensable for the recruitment
and antimicrobial action of neutrophils in a model where acute
vascular leakage drives a rapid inflammatory response that is
independent of adaptive immunity (Fig. 2) (22). Intriguingly,
vaccinated fcgrt/ mice lacking mucosal IgG transport were
protected from bacterial growth to the same extent as WT,
suggesting that protective IgG acts within tissues or reaches the
lumen due to paracellular antibody diffusion in P. aeruginosa
infection (Fig. 2B).
FcRn maintains intracellular stores of IgG in myeloid cells.
We determined the role of FcRn in a model of chronic bacterial
infectionwhere specific IgG levels and adaptive immunity develop
gradually over the course of infection.WT and fcgrt/mice were
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FIG 1 FcRn influences local immunoglobulin (Ig) homeostasis in lung, modulating resident CD103 DC. (A) Relative levels of Ig isotypes in serum, homog-
enized lung tissue (Parenchyma), and bronchoalveolar lavage fluid (Lavage) measured by Bioplex. Box and whisker plots show the mean and total and
interquartile ranges of cumulative data from2 experiments where n	 10. Asterisks indicateP values (*,P
 0.05; **,P
 0.01; ***,P
 0.001). (B) Total numbers
of innate and lymphoid immune cells analyzed by flow cytometry in lung. Data points show cumulative data from 3 experiments with the median and
interquartile range. AlvMac, alveolarmacrophage;Mac/mono,macrophage/monocyte. (C) Representative flow cytometry data from the 2 experiments (n	 5),
showing Ly6G-B220-CD11cMHCIIDC from naive lung, as well as a histogram of XCR1 expression on overlaid WT and fcgrt/ CD103DC populations.
FIG 2 FcRn is not required for recruitment of neutrophils or bactericidal
activity in P. aeruginosa infection. WT and fcgrt/ mice were vaccinated in-
tranasally 3 times with paraformaldehyde-fixed P. aeruginosa. At 40 days post-
vaccination, vaccinated mice (i.n vac) and sham controls (PBS) were intratra-
cheally infected with 4 106 P. aeruginosa cells. (A) At 24 h postinfection, the
percentage of lung-infiltrating neutrophils of live cells was measured by flow
cytometry. (B) CFU of P. aeruginosa recovered from lungs 24 h postinfection.
Data show medians and interquartile ranges of representative data from 2
experiments (n 	 5 to 10 per group in each experiment). Asterisks indicate
P values (*, P
 0.05; **, P
 0.01).
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subjected to aerosol infection with M. tuberculosis, and the local
and systemic antibody response was measured in serum, homog-
enized lung tissue, and BALF 28 days after infection. Although
fcgrt/ mice exhibited reduced systemic and lung parenchymal
IgG levels compared toWTmice, we observed similar 10- to 100-
fold increases in the levels of IgG isotypes compared to their rela-
tive baseline levels, suggesting that a B cell response of equivalent
magnitude had developed during tuberculosis (TB) (Fig. 3A). In-
deed, local numbers of B cells in lung tissue increased equally in
the two strains over the course of infection (Fig. 3B). IgG1 and
IgG2b levels in BALF from infected fcgrt/mice approachedWT
levels, indicating that the local antimycobacterial humoral im-
mune response compensated for the reduced half-life of IgG in the
absence of FcRn-mediated rescue from lysosomal degradation.
However, levels of IgG2c and IgG3 in BALF from WT mice in-
creased 10-fold over the baseline levels in an FcRn-dependent
manner, suggesting that these isotypes require active export to the
lung lumen across a functional epithelial barrier during TB (Fig.
3A). Immunofluorescence staining of infectedWT lung tissue in-
dicated that IgGwas concentrated within bronchial epithelial cells
but also within infiltrating immune cells (Fig. 3C). Intracellular
reservoirs of IgG2c examined by flow cytometry showed that
FcRn expression maintained depots inside resident alveolar
macrophages and DC but not inside infiltrating neutrophils,
macrophages, and monocytes during infection (Fig. 3D).
FcRnmodifies cell recruitment to granulomas during TB. In
order to investigate whether global FcRn expression affects the
kinetics of leukocytes infiltrating the lung during TB, we per-
formed flow cytometric analysis of M. tuberculosis-infected WT
and fcgrt/ lung tissue. At the early day 14 time point, migratory
innate immune cells such as neutrophils, monocytes, and macro-
phages as well as resident alveolar macrophages were numerically
similar in the presence or absence of FcRn. In contrast, discrepan-
cies in the numbers and proportions of neutrophils, inflammatory
monocytes, and macrophages developed between fcgrt/ and
control animals 1month postinfection, implying that the influx or
survival of inflammatorymyeloid cells declined over the course of
infection (Fig. 4A). Professional antigen-presenting cells, particu-
larly the enlarged CD103 DC population, were also more fre-
quent in fcgrt/ lung during infection (Fig. 4A). Infection with
M. tuberculosis GFP revealed higher proportions and numbers of
infected CD103 DC, suggesting that opsonized M. tuberculosis
interacts with FcRn to inhibit phagocytic or bactericidal capacity
in this population (Fig. 4B; see also Fig. S3 in the supplemental
material). Wemeasured upregulation of CD69, an adhesion mol-
ecule that is upregulated following T cell receptor stimulation per-
mitting ingress from circulation to tissues, on T cells as a proxy
marker of T cell activation. The two murine genotypes displayed
equivalent activated CD8 T cell numbers, but the numbers of
CD4 T cells expressing CD69 were increased in infected fcgrt/
FIG 3 FcRn shapes the prevalence of IgG isotypes in lung after M. tuberculosis infection. WT and fcgrt/ animals were subjected to aerosol infection with M.
tuberculosis. (A) Bioplex analysis of immunoglobulin isotypes on day 28 postinfection in serum, lung tissue homogenate (Parenchyma), or bronchoalveolar
lavage fluid (Lavage). Box and whisker plots show themeans and interquartile and total ranges, and asterisks indicate P values (*, P
 0.05; **, P
 0.01; ***, P

0.001). (B) Flow cytometry quantification of B220 lymphocytes in lung. Panels A and B show pooled data from 2 or 3 replicate experiments per time point (n	
5 to 6 animals per group in each experiment). (C) Representative results of immunohistochemistry of infected WT lung sections performed on day 28 after
infection revealing intracellular IgG2c (green) in addition to nuclear DAPI staining (blue). Scale bars, 100 m (left and middle panels) and 30 m (far right
panel). (D)Median fluorescence intensity (MFI) of intracellular IgG2cmeasured by flow cytometry in various lung-resident and infiltrating immune cells on day
28 postinfection. Data are representative of the results from 2 experiments (n	 4 to 6 animals per group in each experiment).
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mice at day 14 postinfection (Fig. 4C). To verify the increased
T cell immunogenicity of fcgrt/ lungs, purified transgenic T cell
receptor CD4 T cells specific for the mycobacterial antigen 85B
(Ag85B) were transferred intoWT and fcgrt/ recipients 12 days
following infection withM. tuberculosis. At 72 h after the transfer,
the fcgrt/ lung environment drove increased proliferation of
transferred cells as measured by carboxyfluorescein succinimidyl
ester (CFSE) dilution (Fig. 4D).
Gene expression analysis of selected gene transcripts over the
course of infection showed that ongoing inflammation gradually
inhibited fcgrt expression in WT lung tissues. Numerically in-
creased CD103 DC and the corresponding influx of activated
CD4 T cells in fcgrt/ mice correlated with increased mRNA
levels of lymphocyte chemoattractant transcripts such as itgae,
encoding the protein CD103, and the lymphocyte- and DC-re-
cruiting chemokines cxcl19 and ccl21 (see Fig. S1 in the supple-
mental material).
FcRn deficiency leads to a transient decrease in M. tubercu-
losis load and pathology in lung. The idea of the impact of FcRn
on pulmonary immunity was supported by analysis of M. tuber-
culosis growth over the course of disease, which revealed that
fcgrt/ animals were significantly protected from bacterial bur-
den at 2 weeks and to a greater extent at 1 month after infection
(Fig. 5A). Perhaps due to the ongoing suppression of fcgrt tran-
scription during inflammation (see Fig. S1 in the supplemental
material), this transient effect was lost 2 months postinfection
(Fig. 5A). Peripheral organs of fcgrt/ animals were not similarly
protected, suggesting that FcRn does not play a role in dissemina-
tion of M. tuberculosis (Fig. 5B). FcRn was also redundant for M.
tuberculosis uptake by alveolar macrophages in the bronchoalveo-
lar space following infection, as similar numbers of live M. tuber-
culosis could be retrieved from lavaged lung parenchyma fromWT
and fcgrt/ animals 1 day after aerosol administration (Fig. 5C).
Histological analysis of lung tissue showed equivalent levels of
dispersed cellular infiltration in fcgrt/mice, despite the reduced
M. tuberculosis burden in fcgrt/ animals (Fig. 5D). In addition
to the reduced numbers of infiltrating neutrophils observed in
fcgrt/ animals, the immunostaining pattern ofmyeloperoxidase
was diminished within the lesions of fcgrt/ lungs, suggesting
that early control of mycobacterial growth was associated with
limited neutrophilic recruitment to granulomas (Fig. 5E). Thus,
FcRn shapes the efficacy of the unfolding adaptive immune re-
sponse to M. tuberculosis infection in the pulmonary mucosa.
FcRn expressed by hematopoietic and stromal cells inhibits
immunity in TB. Last, we generated bone marrow chimeras to
investigate whether IgG transport via FcRn to and from airways,
or intracellular IgG trafficking via the FcRn within immune cells,
correlated with susceptibility to tuberculosis. Both immune and
nonimmune cells contributed to maintenance of inflammatory
IgG levels in mixed bone marrow chimeras (Fig. 6A). However,
the protective phenotype of fewer neutrophils and decreased M.
tuberculosis burden of fcgrt/mice at 1 month postinfection was
recapitulated only when both hematopoietic and nonhematopoi-
etic cells lacked FcRn (Fig. 6B and C). FcRnmodulated immunity
in both tissues and within mucosal secretions over the course of
M. tuberculosis infection. Our results suggest that both functions
of the FcRn, ongoing IgG transport across tissue barriers and
within intracellular compartments, enhance pathology and in-
hibit bacterial killing during tuberculosis.
FIG 4 FcRn regulation of IgG during tuberculosis favors infiltration of my-
eloid cells and restricts T cell priming. Leukocyte infiltration in WT and
fcgrt/ lung was analyzed by flow cytometry after aerosol infection with M.
tuberculosis. (A) Quantification of the indicated myeloid cell subsets post-
infection. (B) Quantification of the number of innate immune cells in the lung
that were positive for GFP 28 days after infection withM. tuberculosis express-
ing GFP (MTBGFP) compared to the number in the lung of control animals
infected with nonfluorescent H37Rv. (C) Quantification of the number of
CD44hi CD69-expressing CD3 CD4 or CD3 CD8 T cells in lung at the
indicated time points before and after infection. (D) A total of 1 106 trans-
genic TCR P25 CD4 T cells stained with carboxyfluorescein succinimidyl ester
(CFSE) were intravenously transferred into M. tuberculosis-infected WT and
fcgrt/ mice on day 12 following infection. On day 15 postinfection, the
proportion of transferred T cells that underwent cell division was measured as
shown on the representative flow cytometry histograms. All graphs show the
median and interquartile range and cumulative individual data from 2 pooled
experiments where n 	 5 animals per experiment, except panel D, which





















This report reveals the nuanced balance between IgG recycling
and transport by FcRn under homeostatic and inflammatory con-
ditions in the lung. Analysis of the relative levels of FcRn-depen-
dent transport of Ig subclasses inmurine gut led to the proposal of
the affinity hierarchy IgG2a/IgG2c 	 IgG1IgG2bIgG3, and
the relative concentrations of IgG isotypes matched this descend-
ing order of FcRn binding (23). However, we observed increased
levels of IgG2b and IgG3 compared to IgG2c in the lung, though
these isotypes were present at similar concentrations in the serum
and lung parenchyma. Thus, the IgG isotypes with the lowest af-
finity for FcRn are found at the highest concentration in lung
secretions, leading counterintuitively to a divergence from serum
isotype ratios in an inverse relationship to affinity for the receptor.
A similar pattern was described in mammary secretions and
healthy human lungs (24–26), and it has been suggested that high-
affinity IgG1 and IgG2c antibodies locally saturate FcRn, resulting
in preferential release of low-affinity IgG3 and IgG2b into the
lumen. The prevalent IgG2b and IgG3 isotypes have relatively in-
creased bactericidal and opsonizing properties (27), and perhaps
their dominance represents an adaptation maintained by FcRn in
order to maximize the sterilizing efficacy of mucosal antibody in
the lung. However, the same processes could damage sensitive
tissues during the persistent inflammation that characterizes tu-
berculosis. Parallels may be drawn between the detrimental ac-
tions of FcRn in this model and previous findings showing that it
can promote IgG complex-mediated tissue pathology in autoim-
mune inflammatory disorders (28–30). Indeed, specific antago-
nists of FcRn are being pursued as novel therapeutic measures for
this reason (31).
Our data frommurine P. aeruginosa infection support the no-
tion that FcRn-mediated IgG transport into the lumen becomes
redundant under inflammatory conditions because paracellular
transport and vascular leakage bypass the receptor (8, 10). Un-
FIG 6 Stromal and immune cells expressing FcRn contribute to transient
uncontrolled bacterial growth in tuberculosis. Lethally irradiated WT and
fcgrt/mice were reconstituted with WT or fcgrt/ bone marrow to create
mixed or control chimeric mice, which were subjected to aerosol infection
withM. tuberculosis and sacrificed 28 days later for analysis. (A) Specific IgG in
serum and lung homogenate was quantified by ELISA. KO, knockout. (B)
Ly6G CD11b neutrophils were measured as a proportion of live cells by
flow cytometry. (C) Bacterial loads were quantified in the lung and spleen.
Graphs show the medians and interquartile ranges of representative results
from two experiments (n 	 4 to 6 per group in each experiment). Asterisks
indicate the P value (*, P
 0.05).
FIG5 FcRn transiently affects disease progression in the lung during tuberculosis.WT and fcgrt/micewere subjected to aerosol infectionwithM. tuberculosis.
(A) CFU levels in lung were measured at various time points. (B) CFU levels in spleen and liver were measured at day 28 after infection. (C) Quantification of
parenchymalM. tuberculosis was performed by plating total lung homogenates following bronchoalveolar lavage 1 day after infection. Graphs show cumulative
data and the medians and interquartile ranges of the results of 2 experiments (n	 4 to 9 per group in each experiment). Asterisks indicate P values (*, P
 0.05;
****, P
 0.0001). (D and E) Representative histology sections of lung at day 28 postinfection showing the results of stainingwith hematoxylin and eosin to reveal
immune infiltrated areas (D) and of immunofluorescent staining for myeloperoxidase (red) and cell nuclei (blue) (E). Scale bars, 1,000 m.
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compromised immunity to P. aeruginosa infection in fcgrt/
lung and equivalent uptake of M. tuberculosis GFP by neutrophils
suggest a limited cell-intrinsic role for FcRn in neutrophil func-
tion in vivo during acute infection. This contrasts with in vitro
studies showing that FcRn is required for optimal granulocyte
phagocytosis of IgG-coated, heat-killed Streptococcus pneumoniae
(32), but perhaps other phagocytic receptors or pathogen-specific
determinants can compensate for FcRn-Ig interactions in vivo.
The slight difference in M. tuberculosis burdens in lung at day 14,
before the arrival of CD4 T cells and production of specific IgG,
is therefore surprising and leaves room for the possibility that
FcRn can influence intracellular bacterial replication or local pro-
duction of bactericidal peptides.
Numerous studies have shown that the early recruitment of
CD4 T cells to the lung is the dominant factor determining bac-
terial control and lung pathology during tuberculosis (16, 33).
Our studies join a growing body of literature showing that failed T
cell responses result in excessive inflammation during tuberculo-
sis in humans, primates, and mice, in association with increased
bacterial load (34, 35). CD103 DC have been observed to pro-
mote increased Th1 andTh17CD4T cell responses in vitro com-
pared to monocyte-derived CD11b DC, T helper subsets that
have been shown to be particularly beneficial during TB (36, 37).
It is tempting to speculate that the numerical increase of both
infected and bystander CD103 DC in fcgrt/ mice maintains
improved T cell priming in tuberculosis. Perplexingly, FcRn has
previously been reported to aid uptake and presentation of IgG-
complexed antigen for CD4 and CD8T cells by CD11bDC in
several models (38, 39). Yet, during tuberculosis, we observed the
inverse phenomenon of increased infection rates and T cell acti-
vation in the absence of the receptor at the early day 14 time point
after infection, and, even when bacterial growth rates diverged
betweenWT and fcgrt/mice by day 28, similar levels of CD4T
cell activation could be observed despite the lower antigenic bur-
den in protected fcgrt/ animals. Perhaps DC in various tissue
compartments have different requirements for the receptor, or
perhaps the solubility of Ig antigen complexes and their interac-
tions with FcRn differ between model systems. The striking in-
crease in resident lung DC observed in fcgrt/ mice during ho-
meostasis emphasizes that the role of FcRn during myeloid cell
development in tissues should be targeted in future studies.
We observed that increased flt3 transcript expression corre-
lated with an expanded CD103 DC population in fcgrt/ ani-
mals, supporting previous publications showing the systemic im-
portance of this growth factor for DC development (40, 41). The
explanation of how local IgG or commensal microbes may inhibit
lung DC development or recruitment via FcRn remains elusive.
Analysis of contrived commensal colonization of germfree
fcgrt/ animals or acquisition of lung immunity in neonates will
have to address this issue in the future. Interestingly, an elegant
study by Koch et al. recently showed a strikingly similar phenom-
enon in neonatal gut, where maternal IgG2b and IgG3 in the mu-
cosa suppressed downstream T cell priming to mucosal antigens
(42). Our results confirm that local dendritic cells are influenced
by the prevailing signals derived from mucosal IgG during devel-
opment. Mucosal IgG may limit access of antigens to lung or
draining lymph nodes, as was previously shown to be the case in
the context of barrier integrity of the gut epithelium in neonates
(43).
Our results clearly demonstrate an indirect role for IgG in
modulating cell recruitment to granulomas. We have shown here
that the quantity and quality of IgG in airways are maintained by
FcRn,which negatively impacts homeostatic populations ofDC in
the lung and subsequent T cell immunity and neutrophil recruit-
ment during tuberculosis. This novel understanding of tissue-spe-
cific modulation of mucosal IgG isotypes in the lung by FcRn
sheds light on the role ofmucosal IgG for immune responses in the
lung during homeostasis and bacterial disease.
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